Ignite Creation Date:
2024-05-05 @ 7:41 PM
Last Modification Date:
2024-10-26 @ 9:52 AM
Study NCT ID:
NCT00714948
Status:
TERMINATED
Last Update Posted:
2015-11-16
First Post:
2008-07-10
Brief Title:
Gemcitabine and Split-dose Cisplatin GC Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Sponsor:
Organization:
Memorial Sloan Kettering Cancer Center